Gossamer Bio (GOSS)
(Delayed Data from NSDQ)
$1.98 USD
-0.18 (-8.33%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $1.98 0.00 (0.00%) 4:34 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Gossamer Bio, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GOSS 1.98 -0.18(-8.33%)
Will GOSS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GOSS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GOSS
Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates
Harmony Biosciences Holdings, Inc. (HRMY) Misses Q2 Earnings and Revenue Estimates
GOSS: What are Zacks experts saying now?
Zacks Private Portfolio Services
GSK (GSK) Q2 Earnings and Revenues Beat Estimates
Gossamer Bio (GOSS) Reports Q1 Loss, Tops Revenue Estimates
Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates
Other News for GOSS
GOSS: Wedbush Raises Gossamer Bio Price Target to $5 Following Outperform Rating | GOSS Stock News
Gossamer Bio GAAP EPS of -$0.17 in-line, revenue of $11.49M beats by $6.08M
GOSS Achieves Strong Q2 Revenue and Prepares for Commercial Expansion
Gossamer Bio reports Q2 EPS (17c) , consensus (18c)
BlackRock, Inc. Expands Holdings in Gossamer Bio Inc.